John Reed at JPM 2019. Jeff Rumans for Endpoints News
Sanofi's John Reed continues to reorganize R&D, cutting 466 jobs while boosting cancer, gene therapy research
The R&D reorganization inside Sanofi is continuing, more than a year after the pharma giant brought in John Reed to head the research arm of the Paris-based company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
